Cargando…

Therapeutic potential of pyruvate therapy for patients with mitochondrial diseases: a systematic review

BACKGROUND: Mitochondrial disease is a term used to describe a set of heterogeneous genetic diseases caused by impaired structure or function of mitochondria. Pyruvate therapy for mitochondrial disease is promising from a clinical point of view. METHODS: According to PRISMA guidelines, the following...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Zhou, Shuang, Chen, Chaoyang, Ma, Lingyun, Luo, Daohuang, Tian, Xin, Dong, Xiu, Zhou, Ying, Yang, Yanling, Cui, Yimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350055/ https://www.ncbi.nlm.nih.gov/pubmed/32695307 http://dx.doi.org/10.1177/2042018820938240

Ejemplares similares

Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies
por: Ma, Lingyun, et al.
Publicado: (2020)

Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta‐analysis of randomized controlled trials
por: Qu, Jinghan, et al.
Publicado: (2019)

Function of mitochondrial pyruvate carriers in hepatocellular carcinoma patients
por: Ma, Xiangming, et al.
Publicado: (2018)

Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials
por: Zhang, Enyao, et al.
Publicado: (2021)

Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients With Multiple Sclerosis: Analyses of Published Clinical Trials
por: Chaoyang, Chen, et al.
Publicado: (2022)

The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier
por: Zangari, Joséphine, et al.
Publicado: (2020)

Efficacy and safety of ketoconazole combined with calmodulin inhibitor in solid organ transplantation: A systematic review and meta‐analysis
por: Xue, Ting, et al.
Publicado: (2019)

Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1
por: Li, Aiyun, et al.
Publicado: (2018)

Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy
por: Zhu, Huanhuan, et al.
Publicado: (2020)

Withdrawal: Mitochondrial pyruvate carrier blockade results in decreased osteoclastogenesis and bone resorption via regulating mitochondrial energy production
por: Guo, Qian, et al.
Publicado: (2022)

The role of pyruvate kinase M2 in anticancer therapeutic treatments
por: Su, Qiongli, et al.
Publicado: (2019)

Targeting the Mitochondrial Pyruvate Carrier for Neuroprotection
por: Tang, Bor Luen
Publicado: (2019)

The Prevalence and Antibiotic-Resistant of Listeria monocytogenes in Livestock and Poultry Meat in China and the EU from 2001 to 2022: A Systematic Review and Meta-Analysis
por: Zhang, Haoqi, et al.
Publicado: (2023)

Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis
por: Li, Min, et al.
Publicado: (2019)

The Role of Pyruvate Metabolism in Mitochondrial Quality Control and Inflammation
por: Kim, Min-Ji, et al.
Publicado: (2023)

Pyruvate as a Potential Beneficial Anion in Resuscitation Fluids
por: Zhou, Fang-Qiang
Publicado: (2022)

The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma
por: Findlay, Steven, et al.
Publicado: (2023)

Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas
por: Jha, Mithilesh Kumar, et al.
Publicado: (2013)

The long and winding road to the mitochondrial pyruvate carrier
por: Schell, John C, et al.
Publicado: (2013)

Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes
por: Nishi, Kiyoto, et al.
Publicado: (2023)

Efficacy of Therapeutic Endoscopy for Gastrointestinal Lesion (GI): A network meta-analysis
por: Wang, Tian-xi, et al.
Publicado: (2019)

Mitochondrial pyruvate carrier 1 mediates abscisic acid-regulated stomatal closure and the drought response by affecting cellular pyruvate content in Arabidopsis thaliana
por: Shen, Jian-Lin, et al.
Publicado: (2017)

A highly responsive pyruvate sensor reveals pathway-regulatory role of the mitochondrial pyruvate carrier MPC
por: Arce-Molina, Robinson, et al.
Publicado: (2020)

Mitochondrial Pyruvate Carrier Subunits Are Essential for Pyruvate-Driven Respiration, Infectivity, and Intracellular Replication of Trypanosoma cruzi
por: Negreiros, Raquel S., et al.
Publicado: (2021)

Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
por: Xie, Wenjia, et al.
Publicado: (2023)

Heart failure—emerging roles for the mitochondrial pyruvate carrier
por: Fernandez-Caggiano, Mariana, et al.
Publicado: (2021)

Mitochondrial Pyruvate Carriers are Required for Myocardial Stress Adaptation
por: Zhang, Yuan, et al.
Publicado: (2020)

Experimental Investigations on the Structure of Yeast Mitochondrial Pyruvate Carriers
por: Li, Ling, et al.
Publicado: (2022)

Therapeutic effect of autologous bone grafting with adjuvant bone morphogenetic protein on long bone nonunion: a systematic review and meta-analysis
por: Xie, Chengxin, et al.
Publicado: (2022)

Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2–dependent glutaminolysis pathway
por: Wei, Peng, et al.
Publicado: (2022)

Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
por: HUR, HOON, et al.
Publicado: (2012)

Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials
por: Zhao, Min, et al.
Publicado: (2022)

The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
por: McCommis, Kyle S., et al.
Publicado: (2023)

Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs
por: Hu, Chao-Jun, et al.
Publicado: (2021)

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017)

Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter
por: Nagampalli, Raghavendra Sashi Krishna, et al.
Publicado: (2018)

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)

Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
por: Fernandez-Caggiano, Mariana, et al.
Publicado: (2020)

Mitochondrial Pyruvate Carrier Function in Health and Disease across the Lifespan
por: Buchanan, Jane L., et al.
Publicado: (2020)

Mitochondrial pyruvate carrier is required for optimal brown fat thermogenesis
por: Panic, Vanja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vip39e3hs1167277744p0nr3c5